Merck (NYSE: MRK) is slated to release its Q4 and full-year 2019 results on February 5, 2020. We don’t expect the company to beat, but rather meet, the average consensus EPS of $5.17. For full year 2019, Trefis estimates that the company will report Revenues of $46.6 billion, reflecting 10.1%...
